HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion

被引:19
作者
Karp, C. M. [1 ]
Shukla, M. N. [1 ]
Buckley, D. J. [1 ]
Buckley, A. R. [1 ]
机构
[1] Univ Cincinnati, Acad Hlth Ctr, Coll Pharm, Cincinnati, OH 45267 USA
关键词
HRPAP20; calmodulin; MMP-9; tumor invasion; metastasis; breast cancer;
D O I
10.1038/sj.onc.1209980
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously reported the identification of HRPAP20 (hormone-regulated proliferation-associated protein 20), a novel hormone-regulated, proliferation-associated protein. In tumor cell lines, constitutive HRPAP20 expression enhanced proliferation and suppressed apoptosis, characteristics frequently associated with malignant progression. Here, we report that highly invasive breast cancer cell lines and human breast tumor specimens express elevated HRPAP20, which in transfection experiments in MCF-7 and MDA-MB-231 cells, increased invasion. Results from mechanistic studies revealed that HRPAP20 bound to calmodulin (CaM) via a conserved CaM-binding motif. Transfection of MCF-7 breast cancer cells with HRPAP20 harboring a mutated CaM-binding motif (HRPAP20K73A) inhibited its interaction with CaM and failed to increase invasion. Other experiments revealed that transfection with HRPAP20, but not HRPAP20K73A, increased secretion of matrix metallo-proteinase-9 (MMP-9). Moreover, knockdown of HRPAP20 with small interfering RNA in MCF-7/HRPAP20 transfectants and wild-type MDA-MB-231 cells reduced invasion and inhibited secretion of MMP-9. Together these observations suggest that HRPAP20 may be an important regulator of breast tumor cell invasion by a CaM-mediated mechanism that leads to increased MMP-9 secretion. We conclude that dysregulation of HRPAP20 expression in tumor cells may contribute to the observed phenotypic changes associated with breast cancer progression.
引用
收藏
页码:1780 / 1788
页数:9
相关论文
共 45 条
[1]   Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin [J].
Agell, N ;
Bachs, O ;
Rocamora, N ;
Villalonga, P .
CELLULAR SIGNALLING, 2002, 14 (08) :649-654
[2]  
ALBINI A, 1987, CANCER RES, V47, P3239
[3]  
ARAFAH BM, 1986, CANCER RES, V46, P3268
[4]  
BAGCHI IC, 1992, J BIOL CHEM, V267, P3024
[5]   Matrix metalloproteinase expression in breast cancer [J].
Bartsch, JE ;
Staren, ED ;
Appert, HE .
JOURNAL OF SURGICAL RESEARCH, 2003, 110 (02) :383-392
[6]   Heme oxygenase-2 is activated by calcium-calmodulin [J].
Boehning, D ;
Sedaghat, L ;
Sedlak, TW ;
Snyder, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (30) :30927-30930
[7]   MOLECULAR AND STRUCTURAL BASIS OF TARGET RECOGNITION BY CALMODULIN [J].
CRIVICI, A ;
IKURA, M .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 1995, 24 :85-116
[8]  
Di Carlo A, 2005, INT J ONCOL, V26, P1363
[9]   Understanding breast cancer risk - where do we stand in 2005? [J].
Dumitrescu, RG ;
Cotarla, I .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2005, 9 (01) :208-221
[10]  
Ellis MJ, 2003, ADV EXP MED BIOL, V532, P223